1. Home
  2. WH vs MDGL Comparison

WH vs MDGL Comparison

Compare WH & MDGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WH
  • MDGL
  • Stock Information
  • Founded
  • WH 2017
  • MDGL 2011
  • Country
  • WH United States
  • MDGL United States
  • Employees
  • WH N/A
  • MDGL N/A
  • Industry
  • WH Hotels/Resorts
  • MDGL Biotechnology: Pharmaceutical Preparations
  • Sector
  • WH Consumer Discretionary
  • MDGL Health Care
  • Exchange
  • WH Nasdaq
  • MDGL Nasdaq
  • Market Cap
  • WH 6.5B
  • MDGL 6.1B
  • IPO Year
  • WH N/A
  • MDGL N/A
  • Fundamental
  • Price
  • WH $79.34
  • MDGL $285.73
  • Analyst Decision
  • WH Strong Buy
  • MDGL Strong Buy
  • Analyst Count
  • WH 11
  • MDGL 9
  • Target Price
  • WH $108.07
  • MDGL $420.63
  • AVG Volume (30 Days)
  • WH 967.1K
  • MDGL 291.4K
  • Earning Date
  • WH 07-23-2025
  • MDGL 08-06-2025
  • Dividend Yield
  • WH 2.08%
  • MDGL N/A
  • EPS Growth
  • WH 48.31
  • MDGL N/A
  • EPS
  • WH 4.22
  • MDGL N/A
  • Revenue
  • WH $1,416,000,000.00
  • MDGL $317,383,000.00
  • Revenue This Year
  • WH $7.69
  • MDGL $286.17
  • Revenue Next Year
  • WH $6.55
  • MDGL $64.17
  • P/E Ratio
  • WH $18.64
  • MDGL N/A
  • Revenue Growth
  • WH 2.61
  • MDGL N/A
  • 52 Week Low
  • WH $70.08
  • MDGL $200.63
  • 52 Week High
  • WH $113.07
  • MDGL $377.46
  • Technical
  • Relative Strength Index (RSI)
  • WH 38.17
  • MDGL 48.91
  • Support Level
  • WH $78.82
  • MDGL $275.00
  • Resistance Level
  • WH $81.83
  • MDGL $303.45
  • Average True Range (ATR)
  • WH 1.82
  • MDGL 10.81
  • MACD
  • WH -0.31
  • MDGL 1.70
  • Stochastic Oscillator
  • WH 11.67
  • MDGL 49.02

About WH Wyndham Hotels & Resorts Inc.

As of Dec. 31, 2024, Wyndham Hotels & Resorts operates 903,000 rooms across more than 20 brands predominantly in the economy and midscale segments. Super 8 is the largest brand, representing around 18% of all rooms, with Days Inn (13%) and Ramada (14%) the next two largest brands. During the past several years, the company has expanded its extended stay/lifestyle brands, which appeal to travelers seeking to experience the local culture of a given location. The company closed its La Quinta acquisition in the second quarter of 2018, adding around 90,000 rooms at the time the deal closed. Wyndham launched a new extended stay economy scale segment concept, ECHO, in the spring of 2022. The United States represents 56% of total rooms.

About MDGL Madrigal Pharmaceuticals Inc.

Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, and premature mortality. The company's medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor agonist designed to target key underlying causes of MASH.

Share on Social Networks: